| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/19/2005 | EP1497672A2 Ultrasonic doppler effect speed measurement |
| 01/19/2005 | EP1497470A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 01/19/2005 | EP1497435A2 Placental derived stem cells and uses thereof |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497329A1 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497313A2 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 01/19/2005 | EP1497309A2 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1497296A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 01/19/2005 | EP1497294A1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 01/19/2005 | EP1497293A1 (1,4)diazepino(6,7,1-ij)quinoline derivatives as anti psychotic and antiobesity agents |
| 01/19/2005 | EP1497291A2 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands |
| 01/19/2005 | EP1497288A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament |
| 01/19/2005 | EP1497285A1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 01/19/2005 | EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497266A2 Quinoline derivatives and their use as 5-ht6 ligands |
| 01/19/2005 | EP1497265A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497257A1 2,5-bis-diamine-[1,4] benzoquinone derivatives for the treatment of alzheimer's disease, a process for their preparation and intermediates therefor |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497250A1 Hyperforin derivatives, the use thereof and formulations containing them |
| 01/19/2005 | EP1497249A1 Hyperforin halogenated derivatives, the use thereof and formulations containing them |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1496940A2 Methods of treating diabetes using pde 11a inhibitors |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496924A2 Treatment of gastroparesis |
| 01/19/2005 | EP1496920A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496915A1 Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
| 01/19/2005 | EP1496914A1 (20S)-1a-HYDROXY-2a-METHYL AND 2&bgr;-METHYL-19-NOR-VITAM IN D sb 3 /sb AND THEIR USES |
| 01/19/2005 | EP1496913A2 Neuroprotective spirostenol pharmaceutical compositions |
| 01/19/2005 | EP1496907A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496905A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/19/2005 | EP1496904A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
| 01/19/2005 | EP1496901A2 Compositions comprising mmp7 modulators for the treatment of chronic pain |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496893A2 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496890A1 Substituted beta-aminoalcohols used as medicaments |
| 01/19/2005 | EP1496881A2 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 01/19/2005 | EP1496873A2 Chewable soft capsule |
| 01/19/2005 | EP1496872A2 Functional foods containing a phospholipid-containing stable matrix |
| 01/19/2005 | EP1496868A1 Controlled release pharmaceutical compositions of carbidopa and levodopa |
| 01/19/2005 | EP1496857A1 Aerosol containing a particulate active substance |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1404812A4 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1379283A4 Identification of target-specific folding sites in peptides and proteins |
| 01/19/2005 | EP1377574B1 6-phenylbenzonaphthyridines |
| 01/19/2005 | EP1368348B1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives |
| 01/19/2005 | EP1355633B1 NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate |
| 01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 01/19/2005 | EP1208104B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/19/2005 | EP1200080A4 Assay for d-serine transport antagonist and use for treating psychosis |
| 01/19/2005 | EP1121127B1 Oral pharmaceutical compositions containing buprenorphin |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | EP0958293B1 Nanomolar, non-peptide inhibitors of cathepsin d |
| 01/19/2005 | EP0642335B2 Controlled release preparation containing a salt of morphine |
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
| 01/19/2005 | CN1568329A Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 01/19/2005 | CN1568323A Activator for peroxisome proliferator-activated receptor delta |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 01/19/2005 | CN1568316A Activator for peroxisome proliferator-responsive receptor delta |
| 01/19/2005 | CN1568313A Piperidine compounds as muscarinic antagonists |
| 01/19/2005 | CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/19/2005 | CN1568309A 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568189A [[2-(amino-3, 4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 01/19/2005 | CN1568188A Nociceptin analogs |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1568184A Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome |
| 01/19/2005 | CN1568181A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/19/2005 | CN1566358A Enzymolysis product of animal brain and its preparation method and pharmaceutical use |
| 01/19/2005 | CN1566132A Schizophrenia susceptible gene----KPNB3 gene and uses thereof |
| 01/19/2005 | CN1566128A Sugar charcoal glycoside isoflavone compound containing alkane amine group and alkoxy substitution, process and uses thereof |
| 01/19/2005 | CN1566126A Novel natural drug effective region |
| 01/19/2005 | CN1566099A Isoquinoline-1, 3, 4-trione compounds, preparation method and uses thereof |
| 01/19/2005 | CN1565601A Application of sichuan lovage rhizome oil by supercritical CO2 extraction method in pharmacy |
| 01/19/2005 | CN1565573A Composition with functions of advancing intelligence, improving brain energetic metabolism and development and increasing dopaminergic neurons capability and the preparing method and usage thereof |
| 01/19/2005 | CN1565563A Headache treating medicine |
| 01/19/2005 | CN1565529A Dripping pills preparation for treating angioneurotic headache |
| 01/19/2005 | CN1565524A Medicine for treating senile dementia and its preparing process |
| 01/19/2005 | CN1565454A Solid preparation for refreshment and its preparation method |
| 01/19/2005 | CN1565452A Neurofender, the novel formulation of preventing and delaying aging and death of human cerebral neurocyte |
| 01/19/2005 | CN1565441A Use of levobutylphthalide in prevention and cure of dementia |
| 01/19/2005 | CN1565438A Use of 5-hydroxymethyl furfural in preparation of drug for nerve system |
| 01/19/2005 | CN1565437A Verapamil hydrochloric acid drop pill and its preparation method |
| 01/19/2005 | CN1565434A Orally administered Modafinil medicine compostion |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185228C Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |